Free Access
Issue
J Extra Corpor Technol
Volume 40, Number 4, December 2008
Page(s) 241 - 248
DOI https://doi.org/10.1051/ject/200840241
Published online 15 December 2008
  1. Arnold P, Jackson S, Wallis J, Smith J, Bolton D, Haynes S. Coagulation factor activity during neonatal extra-corporeal membrane oxygenation. Intensive Care Med. 2001;27:1395–400. [CrossRef] [PubMed] [Google Scholar]
  2. Dominguez T, Mitchell M, Friess SH, et al. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2005;6:348–51. [CrossRef] [PubMed] [Google Scholar]
  3. Egan JR, Lammi A, Schell DN, Gillis J, Nunn GR. Recombinant activated factor VII in paediatric cardiac surgery. Intensive Care Med. 2004;30:682–5. [CrossRef] [PubMed] [Google Scholar]
  4. MacLaren R, Weber LA, Brake H, Gardner MA, Tanzi M. A multicenter assessment of recombinant factor VIIa off-label usage: Clinical experiences and associated outcomes. Transfusion. 2005;45:1434–42. [CrossRef] [PubMed] [Google Scholar]
  5. Pychynska-Pokorsda M. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med. 2004;5:246–50. [CrossRef] [PubMed] [Google Scholar]
  6. Razon Y, Erez E, Vidne B, et al. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth. 2005;15:235–40. [CrossRef] [PubMed] [Google Scholar]
  7. Tobias JD, Groeper K, Berkenbosch JW. Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J. 2003;96:12–6. [CrossRef] [PubMed] [Google Scholar]
  8. Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med. 2004;19:270–3. [CrossRef] [PubMed] [Google Scholar]
  9. Wittenstein B, Ng C, Ravn H, Goldman A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med. 2005;6:473–6. [CrossRef] [PubMed] [Google Scholar]
  10. Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs. 1999;23:979–83. [CrossRef] [PubMed] [Google Scholar]
  11. Raivio P, Suojaranta-Ylinen R, Kuitunen AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg. 2005;80:66–71. [CrossRef] [Google Scholar]
  12. Bui J, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002;124:852–4. [CrossRef] [Google Scholar]
  13. De Gasperi A. Intraoperative use of recombinant activated factor VII (rFVIIa). Minerva Anestesiol. 2006;72:489–94. [Google Scholar]
  14. DiDomenico RJ, Massad MG, Kpodonu J, Navarro RA, Geha AS. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass. Chest. 2005;127:1828–35. [CrossRef] [PubMed] [Google Scholar]
  15. von Heymann C, Redlich U, Jain U, et al. Recombinant activated factor VII for refractory bleeding after cardiac surgery: A retrospective analysis of safety and efficacy. Crit Care Med. 2005;33:2241–6. [CrossRef] [PubMed] [Google Scholar]
  16. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb. 2002;32(Suppl):41–6. [CrossRef] [PubMed] [Google Scholar]
  17. Warren O, Mandal K, Hadjianastassiou V, et al. Recombinant activated factor VII in cardiac surgery: A systematic review. Ann Thorac Surg. 2007;83:707–14. [CrossRef] [Google Scholar]
  18. van de Garde EMW, Bras LJ, Heijmen RH, et al. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2006;20:573–5. [CrossRef] [Google Scholar]
  19. Karkouti K, Beattie WS, Wijeysundera DN, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery; a propensity score matched case control analysis. Transfusion. 2005;45:26–34. [CrossRef] [PubMed] [Google Scholar]
  20. Bishop C, Renwick WEP, Hogan C, Haeusler M, Tuckfield A, Tatoulis J. Recombinant activated factor VII: Treating postoperative hemorrhage in cardiac surgery. Ann Thorac Surg. 2006;81:875–9. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.